Vimarsana
Biggest News Aggregation in the World

Processa Ngcs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Processa Ngcs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Processa Ngcs Today - Breaking & Trending Today

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research - Vimarsana News

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research

Brings extensive experience in all phases of oncology drug developmentHANOVER, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals,...

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference - Vimarsana News

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference

HANOVER, MD, Feb. 14, 2024 -- Processa Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy...

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering - Vimarsana News

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering

HANOVER, Md., Jan. 26, 2024 -- Processa Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy...

Processa Pharmaceuticals Issues Letter to Shareholders - Vimarsana News

Processa Pharmaceuticals Issues Letter to Shareholders

HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...

Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug Congress - Vimarsana News

Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug Congress

22.05.2023 - Company also to provide a corporate overview in a separate session HANOVER, MD, May 22, 2023 (GLOBE NEWSWIRE) - Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on ...